VitaNova Life Sciences (VNOV) Return on Capital Employed (2019 - 2026)

VitaNova Life Sciences has reported Return on Capital Employed for 6 years, with the latest figure at 64.08% in Q1 2026.

• For the quarter ending Q1 2026, Return on Capital Employed rose 3077.0% year-over-year to 64.08%; the trailing twelve-month figure through Jan 2026 stood at 64.08% (up 3077.0% YoY), and the FY2025 full-year result was 87.75%, up 4342.0% from the prior year.
• Return on Capital Employed for Q1 2026 stood at 64.08%, down from 67.95% in the prior quarter.
• The five-year high for Return on Capital Employed was 166.8% in Q1 2022, with the low at 96.78% in Q4 2022.
• Historically, Return on Capital Employed has averaged 42.04% across 5 years, with a median of 41.8% in 2023.
• Annual changes were most pronounced in 2023 — Return on Capital Employed plunged 12491 bps — and 2025, when it jumped 6201 bps.
• VitaNova Life Sciences' Return on Capital Employed stood at 96.78% in 2022, then jumped by 143 bps to 41.72% in 2023, then plunged by 39 bps to 25.43% in 2024, then jumped by 167 bps to 67.95% in 2025, then fell by 6 bps to 64.08% in 2026.
• The last three Return on Capital Employed figures came in at 64.08% (Q1 2026), 67.95% (Q4 2025), and 65.33% (Q3 2025), per Business Quant data.